March 2012
Volume 53, Issue 14
ARVO Annual Meeting Abstract  |   March 2012
Sorsby Fundus Dystrophy S156C-TIMP3 mutation promotes angiogenesis and choroidal neovascularization via an MMP2-dependent mechanism
Author Affiliations & Notes
  • Jian H. Qi, Sr.
    Ophthalmic Research-Cole Eye Inst,
    Cleveland Clinic, Cleveland, Ohio
  • Heidi Stoehr
    Human Genetics, University of Regensburg, Regensburg, Germany
  • Bela Anand-Apte
    Cleveland Clinic, Cleveland, Ohio
  • Footnotes
    Commercial Relationships  Jian H. Qi, Sr., None; Heidi Stoehr, None; Bela Anand-Apte, None
  • Footnotes
    Support  National Institute of Health EY016490, EY015638, Unrestricted Grant from Research to Prevent Blindness and RPB Lew Wasserman award to BA-A.
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 3016. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jian H. Qi, Sr., Heidi Stoehr, Bela Anand-Apte; Sorsby Fundus Dystrophy S156C-TIMP3 mutation promotes angiogenesis and choroidal neovascularization via an MMP2-dependent mechanism. Invest. Ophthalmol. Vis. Sci. 2012;53(14):3016.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : TIMP3 is a regulator of matrix metalloproteinases (MMPs) and a potent angiogenesis inhibitor. Mutations in the TIMP3 gene cause Sorsby Fundus Dystrophy (SFD), an inherited, early onset macular degenerative disorder. SFD closely resembles age-related macular degeneration (AMD), including the development of choroidal neovascularization (CNV). We have demonstrated previously that expression of SFD-related S156C mutation in human retinal pigment epithelial (RPE) cells reduces MMP inhibition and may promote angiogenesis. The objective of this study was to detertmine if S156C-TIMP3 mutation promotes angiogenesis or CNV via an MMP dependent mechanism.

Methods: : Methods: Human RPE cells expressing WT and S156C-TIMP3 or empty vector as well as the RPE-choroid tissue of Timp3 S156C/S156C knock-in mice and their corresponding WT littermates were analyzed by reverse zymography and zymography to detect MMP inhibitory activity and gelatinase activity respectively. ELISAs were used to measure MMP2, MMP9, bFGF or VEGF. An in vitro tube formation assay was utilized to analyze angiogenic responses in endothelial cells . In vivo CNV response in mice was quantitated following laser-induced photocoagulation.

Results: : S156C-TIMP3 reduced MMP inhibitory activity, increased total MMP2 (pro- and active forms) and bFGF but had no effect on MMP9 and VEGF levels in the conditioned medium (CM) of RPE cells relative to vector controls. In contrast, either WT-TIMP3 or a selective MMP2/MMP9 inhibitor (SB-3CT) inhibited bFGF and VEGF release. Addition of CM from mutant RPE cells to either PAE cells expressing FGF receptor-1 (PAE/FGFR-1) or VEGF receptor-2 (PAE/VEGFR-2) induced increased tube formation in three-dimensional (3D) collagen gels with bFGF and VEGF dependency. Treatment with SB-3CT inhibited mutant cells CM-induced morphogenic effects in PAE/FGFR-1 or PAE/VEGFR-2 cells. Consistent with the results from in vitro experiments, Timp3 S156C/S156C mice showed reduced MMP inhibitory activity and increased active form of MMP2 rather than MMP9 in RPE-choroid tissue, especially after a laser burn. Furthermore, at 2 weeks post-laser induction, the area of CNV at Bruch’s membrane (BM) rupture sites was observed to be significantly larger in mutant mice compared to their WT controls.

Conclusions: : S156C-TIMP3 up-regulates RPE cell-mediated angiogenesis by increasing bFGF and VEGF bio-availability and activity via elevated MMP2, and thereby promotes CNV development.

Keywords: age-related macular degeneration • Bruch's membrane • choroid: neovascularization 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.